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Abstract:  Aim: to compare pregnancy outcomes in type 1 diabetic pregnancies with the general population and the impact of glycemic control (HbA1c) on pregnancy outcomes.
Material and methods: The study group included 55 consecutive pregnant women with type 1 diabetes who attended the Outpatient department of Endocrinology, Diabetes and Metabolic disorders in 
their first trimester of pregnancy. For comparison, data of 22767 deliveries in 2004 year were used, published in “Perinatal outcomes in Republic of Macedonia for year 2004”. The following 
parameters were studied: age, maternal body mass index, diabetes duration, planning of pregnancy, HbA1c values in first, second and third trimester, pre-eclampsia, birth weight, gestational age at 
delivery, mode of delivery, and pregnancy outcomes (spontaneous abortions, perinatal mortality, and major congenital malformations).  
Results:  The perinatal mortality rate was 10,9% and congenital malformation rate was 7,3%, in type 1 diabetic pregnancies compared with 1,1% and 1,9%, respectively in the general population. 
Macrocosmic babies were born in 9,1% of type 1 diabetic pregnancies compared with 1,01% in the general population. The caesarean section rate was 61,8% and 16,1%, respectively, and the preterm 
delivery rate was 25,5% and 6,1%, respectively. Pregnancies with serious adverse outcomes (spontaneous abortion, perinatal mortality and congenital malformations) were characterized by higher 
Values of HbA1c in the first trimester of diabetes type 1 pregnancies
Conclusion: Type 1 diabetic pregnancies have worse outcomes then general population. Planning of pregnancy and rigorous glycaemic control using glucose monitoring before and during early 
pregnancy are crucial for better pregnancy outcomes.                                                                                                                                                                                                                         
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Introduction. Diabetes is the most common pre-existing medical condition complicating pregnancy and It is known to have a substantial impact on maternal, fetal and neonatal outcomes. Women 
with type 1 diabetes have a poor outcome compared with women without diabetes, with increased rates of congenital malformations, pre-eclampsia, premature delivery, perinatal mortality, and risk of 
1
delivering a macrosomic baby.  
Studies suggest that the risk of adverse outcome (malformation and perinatal mortality) is related to poor glycemic control in early pregnancy. The critical time period for optimal glycemic control is 
before 7 weeks' gestation, during early organogenesis. There is a small number of studies which examine the influence of glycemic control on pregnancy outcomes  in the second and third trimester of 
2
pregnancy.
1
Glycated haemoglobin (HbA1c) reflects long-term glycaemic control and is a more accurate and stable measure than fasting and postprandial blood glucose levels .
The aim of this study was to examine the pregnancy outcomes between the pregnancies from type 1 diabetes and general population, and also the influence of HbA1c values on the risk of adverse 
outcome of pregnancy. 
Material and methods. The study was conducted from 02.2007 to 02.2009, in the Outpatient department of Endocrinology, Diabetes and Metabolic disorders in Skopje, R. Macedonia. Fifty five 
consecutive pregnant women with type 1 diabetes and singleton pregnancy who enrolled in first trimester were included in this study. The following parameters were analyzed: patient's age, pre-
pregnancy body mass index (BMI), duration of diabetes, planning of pregnancy, HbA1c in first, second and third trimester, retinopathy, nephropathy, pre-eclampsia,  LGA, gestational age at delivery, 
mode of delivery, pregnancy outcomes (spontaneous abortion, perinatal mortality, major congenital malformation). 
Patients were treated with basal-bolus insulin 4 times per day. According to glicemic profile and HbA1c  every two weeks,  the insulin doses were adjusted. 
Analyzed parameters were compared with the same from the general population. For that purpose were used information from perinatal results of Clinic for Gynecology and Obstetrics, Skopje, R.M. 
In order to understand the influence of HbA1c on the outcomes of pregnancy in patients with type 1 diabetes, we divided them: patients with adverse and normal outcome of pregnancy, and planned 
and not planned pregnancy.
Results.
Table 1. Obstetric compliction and fetal characteristics in pregnancies 
with type 1 diabetes and general population
 
diabetes type 
1 
general 
population RR (95%CI) 
number of patients 55 22767   
premature delivery 14 (25,5%) 1394 (6,1%) 4,2 (2,6-6,6) 
sectio caesariea 34 (61,8%) 3674 (16,1%) 3,8 (3,1-4,7) 
pre-eclampsia 4 (7,3%) 1115 (4,9%) 1,5 (0,6-3,8) 
LGA 5 (9,1%) 231 (1,01%) 8,9 (3,8-20,9) 
spontaneus 
abortion 4 (7,3%) 1013(4,4%) 1,6 (0,6-4,2) 
perinatalen 
mortalitet 6 (10,9%) 253 (1,1%) 9,8 (4,6-21,1) 
congenital 
malformation 4 (7,3%) 83 (1,9%)
*
 3,8 (1,4- 9,9) 
 
*83 were congenital malformation only in capital city in R.M. (from 4315 newborns).
Patients with type 1 diabetes had their first visit at 9th gestational week.
Table 2. Outcomes  from adverse and normal type 1 
diabetes pregnancy 
type 1 diabetes adverse outcome normal outcome p 
total number 8 47   
age (years) 27 (21-37) 26 (18-40) 0,47 
BMI kg/m
2
 23 (22-34) 24,2 (18,5-35) 0,5 
diabetes duration 
(years) 10 (1-22) 9 (1-24) 0,76 
planning pregnancy 1 (12,5%) 25 (53,2%) 0,04 
HbA1c I trim. 9,4 (6,2-14,6) 8,6 (5,4-12,0) 0,04 
HbA1c II trim. 7,2 (4,3-12,3) 7,2 (4,3-10) 0,13 
HbA1c III trim. 6,7 (5,7-9,4) 6,8 (4,7-8,4) 0,4 
retinopathy 2 (25%) 11 (23,4%) 0,9 
nephropathy 1 (12,5%) 3 (6,4%) 0,5 
pre-eclampsia - 4 (8,5%) 0,39 
LGA 1 (12,5%) 4 (8,5%) 0,7 
 
Discussion. This study revealed a high incidence of obstetric complications, spontaneous abortion, perinatal mortality, congenital 
malformations, preterm delivery and macrosomia compared with the general population. Perinatal mortality in this study is higher 
3 4
than the national Danish  and U.K. study (10,9% vs. 5,2% and 6,8%, respectively).  The difference is probably due to the small group 
5,6,7
of women with type 1 diabetes. St.Vincent declaration, as in other countries is not achieved.
Adverse outcomes of pregnancy were associated with statistically significant higher values of HbA1c only in the first trimester of 
pregnancy. Also, women with type 1 diabetes who had planned their pregnancy had statistically significant lower values of HbA1c in 
the first trimester. These data support the hypothesis that the increase in the incidence of fetal malformations and perinatal mortality 
among mothers with type 1 diabetes is associated with maternal hyperglycemia during organogenesis and there after, until 16-18 
2
weeks' gestation.  Women with type 1 diabetes who were planning pregnancy had a better outcomes than those who did not plan the 
pregnancy. Planned pregnancy provides an opportunity to correct eventually not optimal glycemic control and achieve a normal 
outcome of pregnancy in type 1 diabetes. diabetes who were planning pregnancy had a better outcomes than those who did not plan 
the pregnancy. Planned pregnancy provides an opportunity to correct eventually not optimal glycemic control and achieve a normal 
outcome of pregnancy in type 1 diabetes.
Conclusion.Type 1 diabetic pregnancies have worse outcomes then the general population. Planning of pregnancy and tight glycaemic control before and during early pregnancy are crucial for better 
pregnancy outcomes.
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Newborns of patients with type 1 diabetes were born earlier, 
more often were macrosomic, more pregnancies ended by 
caesarean section and neonatal mortality was significantly 
higher than the general population.
Four neonates were with major congenital 
malformations, two of them died.
Patients with normal outcome were significantly more among  women 
with planned pregnancy than women with an adverse outcome.
Women with planned type 1 diabetes pregnancies had 
statistically significant lower values of HbA1c in the first 
trimester.
Adverse outcomes of pregnancy were associated with statistically 
significant higher values of HbA1c in the first trimester.
Univariant analysis showed that HbA1c in the first trimester is an 
independent predictor of adverse outcome of pregnancy in patients 
with type 1 diabetes.
